Why is Emcure Pharma falling/rising?

As of 24-Jul, Emcure Pharmaceuticals Ltd is currently priced at 1,424.75, reflecting a slight decline of 0.35 points or 0.02%. The stock has been underperforming recently, having fallen for the last two days with a total decline of 0.05%. Despite this, Emcure Pharma is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally positive trend over a longer period. The company has demonstrated strong financial performance with positive results over the last three consecutive quarters, including record net sales and profitability metrics. However, there has been a notable decrease in investor participation, with delivery volume dropping by 27.89% compared to the 5-day average, which may contribute to the recent price decline.
In the broader market context, Emcure Pharmaceuticals has outperformed the Sensex over the past week and month, with returns of 4.65% and 5.54%, respectively, while the Sensex has seen minimal movement. However, year-to-date, the stock has underperformed the benchmark, showing a decline of 0.92% compared to the Sensex's gain of 5.18%. This mixed performance suggests that while Emcure has had strong short-term returns, its overall year-to-date performance is lagging behind the market, which may be influencing investor sentiment and contributing to the stock's recent price movement.